BRD4 Inhibitor-39
BRD4 Inhibitor-39 (compound 12m) is an orally available BRD4 inhibitor with an IC50 value of 0.02 μM. BRD4 Inhibitor-39 induces apoptosis. BRD4 Inhibitor-39 has anti-tumor activity[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Smiles
FC1=CC(Br)=C(C=C1)NC2=C(N=C3N2C=C(N=C3)C4=CN(N=C4)C)C(C=C5)=CN6C5=NN=C6CC
Molecular Formula
C24H19BrFN9
Molecular Weight
532.37
References & Citations
[1]Liu JY, et al. Design, synthesis, and antitumor evaluation of triazolopyridine derivatives as novel inhibitors for BRD4. Eur J Med Chem. 2025 Jan 13;285:117272.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680050-500 1x 500 µL
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401805-100 1x 100 µL
GP2 (Glycoprotein 2) / ZAP75 (GP2/1805), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040796-100 1x 100 µL
Bcl-2 (BCL2/796), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880484-100 1x 100 µL
Progesterone Receptor (PR484), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details